FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “NEUSTIM”, which is offered here for Pharmaceutical preparations for use in reducing the severity of neutropenia and risk of infection in cytotoxic chemotherapy, for the acceleration of myeloid recovery following bone marrow transplantation and for treating neutropenia in patients treated with ganciclovir in aids-related cytomegalovirus retinitis;.
Its status is currently believed to be active. Its class is unavailable. “NEUSTIM” is believed to be currently owned by “GeneMedix plc”.
| Owner: |
GENEMEDIX PLC
Owner Details |
|---|---|
| Description: |
PHARMACEUTICAL PREPARATIONS FOR USE IN REDUCING THE SEVERITY OF NEUTROPENIA AND RISK OF INFECTION IN CYTOTOXIC CHEMOTHERAPY, FOR THE ACCELERATION OF MYELOID RECOVERY FOLLOWING BONE MARROW TRANSPLANTATION AND FOR TREATING NEUTROPENIA IN PATIENTS TREATED WITH GANCICLOVIR IN AIDS-RELATED CYTOMEGALOVIRUS RETINITIS;
|
| Categories: | PHARMACEUTICAL PREPARATIONS USE |